Ocular manifestations of diabetes

Current Opinion in Ophthalmology

Volumn 9, Issue 6, 1998, Pages 64-68

  Recchia, Franco M ^a   Connolly, Brian ^a   Benson, William E ^a  

^a WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; VASCULOTROPIN;

DIABETES MELLITUS; DISEASE COURSE; EYE DISEASE; HUMAN; MORBIDITY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0031693529     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199812000-00011     Document Type: Review

References (27)

1. B gene expression in chronic diabetes. Curr Eye Res 1998, 17:301-307.
2. Chakravarthy U, Hayes RG, Stitt AW, Douglas A: Endothelin expression in ocular tissues of diabetic and insulin-treated rats. Invest Ophthalmol Vis Sci 1997, 38:2144-2151.
3. Tolentino MJ, Adamis AP: Angiogenic factors in the development of diabetic iris neovascularization and retinopathy. Int Ophthalmol Clin 1998, 38:77-94.
4. Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, Adamis AP: Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 1998, 101:1219-1224.
5. Stitt AW, Yong ML, Gardiner TA, Bucala R, Archer DB, Vlassara H: Advanced glycation end products (AGEs) colocalize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol 1997, 150:523-531.
6. Tanaka Y, Katoh S, Hori S, Miura M, Yamashita H: Vascular endothelial growth factor in diabetic retinopathy. Lancet 1997, 349:1520.
7. Tripathi RD, Li J, Tripathi BJ, Chalam KV, Adamis AP: Increased levels of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 1998, 105(2):232-237.
8. Clermont AC, Aiello LP, Mori F, Aiello LM, Bursell S-E: Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 1997, 124:433-446.
9. Skolnick AA: Novel therapies to prevent diabetic retinopathy. JAMA 1997, 278:1480-1481.
10. Cao J, McCleod DS, Merges CA, Lutty GA: Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. Arch Ophthalmol 1998, 116:589-597.
11. Evans DW, Harris A, Danis RP, Arend O, Martin BJ: Altered retrobulbar vascular reactivity in early diabetic retinopathy. Br J Ophthalmol 1997, 81:279-282.
12. Mitchell P, Smith W, Wang JJ, Attebo K: Prevalence of diabetic retinopathy in an older community: the Blue Mountains Eye Study. Ophthalmology 1998, 105:406-411.
13. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR, Turner RC: United Kingdom prospective diabetes study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998, 116:297-303.
14. Krístinsson JK, Hauksdóttir H, Steftnsson E, Jonasson F, Gíslason I: Active prevention in diabetic eye disease: a 4-year follow-up. Acta Ophthalmol Scand 1997, 75:249-254.
15. Hansson-Lundblad, Agarch E, Agardh C-D: Retinal examination intervals in diabetic patients on diet treatment only. Acta Ophthalmol Scand 1997, 75:244-248.
16. Cahill M, Halley A, Codd M, O'Meara N, Firth R, Mooney D, Acheson RW: Prevalence of diabetic retinopathy in patients with diabetes mellitus diagnosed after the age of 70 years. Br J Ophthalmol 1997, 81:218-222.
17. Hirvelä H, Laatikainen L: Diabetic retinopathy in people aged 70 years or older: the Oulu eye study. Br J Ophthalmol 1997, 81:214-217.
18. Klein R: Barriers to prevention of vision loss caused by diabetic retinopathy. Arch Ophthalmol 1997, 115:1073-1074.
19. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A: Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 1995, 102:48-53.
20. Mitchell P, Smaith W, Chey T, Stat M, Healey PR: Open-angle glaucoma and diabetes: the Blue Mountains Eye Study, Australia. Ophthalmology 1997, 104:712-718.
21. Jonas JB, Gründler AE: Prevalence of diabetes mellitus and arterial hypertension in primary and secondary open-angle glaucomas. Graefes Arch Clin Exp Ophthalmol 1998, 236:202-206.
22. Tsujikawa A, Otani A, Takanashi T, Ogura Y: Long-term prognosis of extracapsular cataract extraction and intraocular lens implantation in diabetic patients. Jpn J Ophthalmol 1997, 41:319-323.
23. Wagner T, Knaflic D, Rauber M, Mester U: Influence of cataract surgery on the diabetic eye: a prospective study. German J Ophthalmology 1996, 5:79-83.
24. Fernández-Vigo J, Castro J, Macarro A: Diabetic iris neovascularization: natural history and treatment. Acta Ophthalmol Scand 1997, 75:89-93.
25. Meier P, Wiedemann P: Vitrectomy for traction macular detachment in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 1997, 235:569-574.
26. Chartuvedi N, Sjolie A-K, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z. Fuller JH, and the EUCLID Study Group: Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 1998, 351:28-31.
27. Williams B: Angiotensin II, VEGF, and diabetic retinopathy. Lancet 1998, 351:836-837.